Pharmacoeconomic assessment of oseltamivir in treating influenza--the case of otherwise healthy Danish adolescents and adults.

Pharmacy world & science : PWS

Volumn 26, Issue 6, 2004, Pages 339-345

  Vindt Holm, Majbrit ^a   Gyldmark, Marlene ^a   Holme Hansen, Ebba ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAMIDE DERIVATIVE; ANTIVIRUS AGENT; OSELTAMIVIR;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; DENMARK; ECONOMICS; FEMALE; HUMAN; INFLUENZA; MALE; MIDDLE AGED; MONTE CARLO METHOD; MULTIVARIATE ANALYSIS; QUALITY ADJUSTED LIFE YEAR; STATISTICAL MODEL; TIME; TREATMENT OUTCOME;

ACETAMIDES; ADOLESCENT; ADULT; ANTIVIRAL AGENTS; CLINICAL TRIALS; COST-BENEFIT ANALYSIS; DENMARK; FEMALE; HUMANS; INFLUENZA, HUMAN; MALE; MIDDLE AGED; MODELS, ECONOMIC; MONTE CARLO METHOD; MULTIVARIATE ANALYSIS; OSELTAMIVIR; QUALITY-ADJUSTED LIFE YEARS; TIME FACTORS; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 17144367317     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-004-0559-2     Document Type: Article

References (0)